<?xml version="1.0" encoding="UTF-8"?>
<p>Several phytochemicals isolated from various Artemisia species exhibit significant antiviral activity [
 <xref rid="B76-medicina-57-00217" ref-type="bibr">76</xref>]. ARTs have turned out to be the most promising antiviral drug candidates with activities against hepatitis B and C viruses, human herpes viruses HSV-1 and HSV-2, HIV-1 and influenza virus A in the low micromolar range [
 <xref rid="B77-medicina-57-00217" ref-type="bibr">77</xref>,
 <xref rid="B78-medicina-57-00217" ref-type="bibr">78</xref>,
 <xref rid="B79-medicina-57-00217" ref-type="bibr">79</xref>,
 <xref rid="B80-medicina-57-00217" ref-type="bibr">80</xref>,
 <xref rid="B81-medicina-57-00217" ref-type="bibr">81</xref>,
 <xref rid="B82-medicina-57-00217" ref-type="bibr">82</xref>]. In most cases, ARTs inhibited the central regulatory processes of viral-infected cells (NF-κB or Sp1-dependent pathways), thus blocking the host-cell–type and metabolic requirements for viral replication [
 <xref rid="B80-medicina-57-00217" ref-type="bibr">80</xref>]. 
</p>
